Table 5. . Median survival for patients who received active treatment.

	Number	Median survival (months)	95% CI	Log rank test p-value
Actively treated	106	9.0	3.8–6.2
Combined chemotherapy and radiotherapy:	67	11.5	9.2–12.7	0.0005
– Hypofractionated radiotherapy	23	10.2	5.0–11.5
– Standard radiotherapy	40	12.5	10.3–14.1
– Other radiotherapy	4	5.5	5.5 to not reached
Chemotherapy only	16	5.4	3.1–7.6
Radiotherapy only	23	6.0	2.7–9.0
Glasgow	35	8.3	5.4–10.7	0.75
Brighton	15	10.3	6.6–11.1
Manchester	56	9.2	6.2–12.5
PS score (0–1)	72	8.3	6.2–10.7	0.82
PS score (2–4)	27	9.8	6.0–12.5
Methylated MGMT promoter	21	8.6	4.1–18.1	0.41
Unmethylated MGMT promoter	35	10.2	7.6–11.2

PS: Performance status.